loader2
Partner With Us NRI

Company details

64.35
70.30
54.40
119.25
6M Return -18.88%
1Y Return 16.88%
Mkt Cap.(Cr) 153.28
Volume 19,665
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 19,665

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 86.31 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 25,587.81 -37,752.78
LAST 3M 74,012.99 -52,283.98
LAST 6M 141,118.09 -186,787.74
LAST 12M 210,989.03 -181,030.70

Information

  • About Company
  • Company Info
  • Listing Info
0
30.01%
31.9153
0%
0%
Description
  • Bilcare Ltd is a research-based organization primarily engaged in manufacturing specialty pharmaceutical packaging barrier films. The company provides pharmaceutical research services, clinical services and packaging systems and material. The company`s key products include packaging films, aluminum foils, wrap systems, cold formed blisters, closures and containers, and paper composites. They also offer research services, including preformulation studies, formulation development, analytical research, stability studies, packaging audit and packaging development and design. Bilcare Ltd was incorporated on July 1987 as Bhandari Paper Products Pvt Ltd and converted into a public limited company on Oct. 27, 1994. The name of the company was changed to BI Ltd in the year 2001 and further the name was changed to Bilcare Ltd on October 1, 2003. The company`s plant at Rajgurunagar in Pune is one of its kinds in Asia and the eighth plant of its kind in the world. During the year 1997-98, company completed the project of Paper Tube Plant at Patalganga in Maharashtra. During the year 1999-2000, German Investment and Development company namely DEG - Deutsche Investitions - Und Entwicklungsgesellschaft MBH has subscribed to 21% of the share capital of PT Bhandari Mishindo, a subsidiary of the company. During the year 2002-03, the company introduced seven new unique products for the pharma sector namely Nova, Patina, Ultra, Excel, Super Zing and Venus. During the year 2003-04, the company hived off their Biltube Division in order to focus their core business of manufacture of pharma packaging and research. Also, PT Bhandari Mishindo, a subsidiary company in Indonesia which was formed as an integral part of the Biltube Division was ceased to be a subsidiary of the company. Also, the company promoted Bilcare Singapore Pte Ltd as a wholly owned subsidiary of the company during the year. In July 2005, Bilcare Singapore Pte Ltd, a wholly owned subsidiary of the company acquired pharma research and clinical services business in USA. Thus Bilcare Inc became a subsidiary of the company. In October 2005, the company unveiled their clinical services facility in Pune. This facility will support the pharma companies in packaging and distribution of their clinical supplies and integrate their global clinical trial requirements efficiently. In September 2006, the company acquired DHP Ltd, a UK-based Clinical Trials Services provider through Bilcare (UK) Ltd, a wholly owned subsidiary of Bilcare Singapore Pte Ltd. In May 2007, Bilcare Research announced the launch of the Bilcare Research Academy in partnership with Association of Clinical Research Professionals (ACRP), US. The academy shall open 25 centers in India and other parts of Asia by 2010. In January 2008, Bilcare Singapore has bought 100% of Singular ID, the provider of integrated high technology enterprise brand security system, for a consideration of Singapore Dollar 19.58 million. Bilcare Singapore is a wholly owned subsidiary of the company. In July 2008, Bilcare Ltd and USA based MeadWestvaco Corp jointly acquired the pharmaceutical packaging Company International Labs of St. Petersburg, Florida, USA.

Read More

Registered Address

1028 Shiroli Village, Taluka Khed Rajgurunagar, Pune, Maharashtra, 410505

Tel : 91-02135-304200/204201
Email : investors:bilcare.com
Website : http://www.bilcare.com

Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 526853
NSE Code :
Book Closure Date (Month) :
BSE Group : X
ISIN : INE986A01012

ICICIdirect Bilcare Ltd FAQ

You can buy Bilcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Bilcare Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 25, 2022 04:01 PM the closing price of Bilcare Ltd was ₹ 65.10.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 25, 2022 04:01 PM, the market cap of Bilcare Ltd stood at ₹ 153.28.
The latest PE ratio of Bilcare Ltd as of May 25, 2022 04:01 PM is 0
The latest PB ratio of Bilcare Ltd as of May 25, 2022 04:01 PM is 0.49
The 52-week high of Bilcare Ltd is ₹ 119.25 while the 52-week low is ₹ 54.40 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE